Next Article in Journal
Spatial Transcriptomic Analysis Reveals Associations between Genes and Cellular Topology in Breast and Prostate Cancers
Next Article in Special Issue
Understanding Inequalities in the Uptake of Supportive Care to Improve Practices in the Cancer Care Continuum
Previous Article in Journal
Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
Previous Article in Special Issue
Digital and Interactive Health Interventions Minimize the Physical and Psychological Impact of Breast Cancer, Increasing Women’s Quality of Life: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Large Improvements in Health-Related Quality of Life and Physical Fitness during Multidisciplinary Inpatient Rehabilitation for Pediatric Cancer Survivors

1
Ludwig Boltzmann Institute for Rehabilitation Research, 1100 Vienna, Austria
2
University Hospital of Psychiatry II, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University of Innsbruck, 6020 Innsbruck, Austria
3
Pediatric Rehabilitation Center Leuwaldhof, 5621 St. Veit im Pongau, Austria
4
Oncological Rehabilitation Center, 5621 St. Veit im Pongau, Austria
5
Institute of Psychology, University of Innsbruck, 6020 Innsbruck, Austria
6
University Hospital of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University of Innsbruck, 6020 Innsbruck, Austria
7
VAMED Rehabilitation Center Kitzbuehel, 6370 Kitzbuehel, Austria
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(19), 4855; https://doi.org/10.3390/cancers14194855
Submission received: 7 September 2022 / Revised: 28 September 2022 / Accepted: 30 September 2022 / Published: 4 October 2022
(This article belongs to the Collection Quality of Life in Cancer Rehabilitation)

Abstract

:

Simple Summary

After cancer treatment, children often suffer from various health problems. Rehabilitation can improve their quality of life. We present data for 236 children and 478 parents who filled out questionnaires before and after inpatient rehabilitation. In our sample, both children and parents reported that the quality of life of the children had substantially improved during rehabilitation, especially their physical and psychosocial quality of life. Children also improved in physical exercises and their functional status. Parents and children showed better agreement regarding the child’s health status after rehabilitation than before. A specific method of statistical analysis (performance score) helped to reduce disagreement between parents and children. We therefore conclude that inpatient rehabilitation is effective for children after cancer treatment and that the performance score should be used in research on rehabilitation for children after cancer treatment to have the most accurate results.

Abstract

Rehabilitation is a key element in improving health-related quality of life (HRQOL) for pediatric cancer survivors. The aim of this study was to present data from a multidisciplinary inpatient rehabilitation treatment. Children took part in a four-week multidisciplinary family-oriented inpatient rehabilitation. A total of 236 children (>5–21 years) and 478 parents routinely completed electronic patient-reported outcomes (ePROs), performance-based assessments, and clinician-rated assessments before (T1) and at the end (T2) of rehabilitation. HRQOL was assessed with the PedsQL generic core and PedsQL cancer module. Data were analyzed using repeated measures analysis of variance (ANOVA). Statistically significant improvements with medium to large effect sizes were observed for most HRQOL scales (η2 = 0.09–0.31), as well as performance-based and clinician-rated assessments for physical activity and functional status (η2 > 0.28). Agreement between children’s PROs and parents’ proxy ratings was lower before (rICC = 0.72) than after (rICC = 0.86) rehabilitation. While the concordance between children and parents’ assessment of changes during rehab was low to moderate (r = 0.19–0.59), the use of the performance score led to substantially increased scores (r = 0.29–0.68). The results of this naturalistic observational study thus highlight the benefits of multidisciplinary pediatric inpatient rehabilitation for childhood cancer survivors. The use of the performance score is recommended in this field.

1. Introduction

Over the past few decades, the worldwide incidence of childhood cancer has increased by 13% [1]. Each year, 9.1–17.8 cases (per 100,000 children) of childhood cancer are newly diagnosed in Europe [2]. Compared to adult oncology, children and adolescents represent a unique patient population with distinct features in physiological and cognitive development and are affected by different types of cancer. Three major pediatric cancer diagnoses account for approximately two-thirds of all childhood cancers, namely, leukemias (~30%), central nervous system (CNS) tumors (24–26%), and lymphomas (11–14%) [3,4]. While cancer remains the leading cause of disease-related death among children, the overall mortality has decreased by more than 50% over the past few decades, and overall survival rates have reached >80% [5,6].
Depending on cancer type, location, and stage, treatment may include surgery, chemotherapy, radiotherapy, stem cell transplantation, or immunotherapy. Although treatment regimens have been optimized, there is a significant number of acute and late adverse events, including physical impairment (such as fatigue, cardiotoxicity, and neurocognitive deficits) and decreased psycho-social functioning [7]. Long-term survivors of childhood cancer are at significant risk for treatment-related late effects for life [8,9].
Cancer rehabilitation should be considered a key tool to reach and maintain improved physical and psychosocial functioning [10]. Cancer rehabilitation usually consists of multidisciplinary in-patient or outpatient treatment, such as physiotherapy, psychotherapy, occupational therapy, nutrition counseling, and lifestyle interventions [11,12]. At its core, rehabilitation aims to improve bio-psycho-social aspects of the individual’s health status and health-related quality of life (HRQOL) [13]. Due to the subjective nature of many of those aspects, both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have recommended the use of patient-reported outcome measures (PROMs) in pediatric oncology [14,15]. It is also recommended to complement children’s self-report with caregiver proxy measures [16,17]. Proxy reports are essential when children are neurocognitively impaired, too young, or too ill to respond for themselves [18,19], which is frequently the case in pediatric oncology.
However, the use of proxy reports is somehow problematic, as research has shown that parents consistently overestimated symptoms and underestimated functioning compared to the children’s self-report [20,21,22]. Factors that may influence parent proxy ratings include the child’s age and sex, level of parental education, cultural background, the parents’ own health, QOL, and psychological distress, as well as the parent’s sex [16,23,24,25,26,27]. So far, however, to our best knowledge, no study has investigated the association of patients’ self-reports and the respective parental proxy ratings in oncological rehabilitation for children.
While several studies from oncological rehabilitation in adult patients have shown the beneficial effects of multidisciplinary inpatient cancer rehabilitation [28,29,30,31], there is only limited evidence for rehabilitation in pediatric cancer survivors. Thus, in this study, we (1) investigated the effect of pediatric oncological rehabilitation on patients’ HRQOL, (2) investigated patient–proxy discrepancies in HRQOL ratings, and (3) compared different approaches to minimize discrepancies between patient PRO and parent proxy ratings. To this end, we conducted a longitudinal, single-center, observational study using self- and observer-reported HRQOL as well as functional health aspects in a sample of pediatric cancer survivors. We hypothesized that (a) the pediatric patients would show significant improvements in several aspects of HRQOL and functional health, and (b) children and parents would differ in their assessment of HRQOL.

2. Materials and Methods

2.1. Patient Sample and Recruitment

Data were collected as part of the clinical procedures at the pediatric oncological rehabilitation center “Leuwaldhof” (Sankt Veit im Pongau, Austria). Pediatric cancer survivors took part in a multidisciplinary inpatient rehabilitation treatment. Treatment was also offered to accompanying family members, e.g., parents and siblings. In Austria, the costs for the rehabilitation treatment are covered by social insurance institutions. The typical rehabilitation treatment for pediatric cancer survivors lasted 28 days with 2.5 daily hours of different therapeutic interventions.
Patients and accompanying parents completed the baseline assessment (T1) before being admitted to the rehabilitation clinic, and a second assessment (T2) at the end of their stay. Patients and/or legal guardians signed a written informed consent prior to data collection. Children between 5 and 21 years old completed the self-report version of the questionnaires, and parents independently completed a proxy version of the questionnaires. Data were collected electronically using a multifunctional web-based application called the Life App, which is based on Computer-Based Health Evaluation Software (CHES) [32]. Collected data were used to evaluate the rehabilitation outcomes, and the results were discussed with the patients at the end of the rehabilitation treatment.

2.2. Rehabilitation Treatment

All patients received a set of multidisciplinary therapies including medical and nursing treatment, nutritional counseling, physiotherapy, and psychological therapies. Depending on their specific needs, patients also took part in speech therapy, massage, animal assisted therapy, social counseling, or pedagogical interventions. Patients received a median number of 85 therapy sessions (IQR = 79–95). The frequency of therapeutic units is displayed in Table 1.

2.3. Patient-Reported Outcomes (PROs)

The assessment of health-related quality of life (HRQOL) was conducted using the Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales [33] and the PedsQL 3.0 Cancer Module [34]. The PedsQL 4.0 Generic Core Scales consists of 23 items, which assess five functioning subscales (physical, emotional, social, school, psychosocial), and a total score. The PedsQL 3.0 Cancer Module consists of 27 items to assess eight symptom subscales (pain and hurt, nausea, procedural anxiety, treatment anxiety, worry, cognitive problems, perceived physical appearance, and communication) and a total score [34]. Both questionnaires are available in age-specific versions and offer a patient self-report and an observer/proxy version. Higher values on both measures represent better outcomes (i.e., higher functioning and lower symptom load). The minimal clinically important difference (MCID) for the total score of the PedsQL 4.0 Generic Core Scales is 4.4 points for the child self-report version and 4.5 points for the parent proxy version [33].
As required by the Austrian Health Insurance and Pension Fund, individual rehabilitation goals are discussed with patients at the beginning of the rehabilitation treatment [35]. At the end of the treatment, rehabilitation outcome is evaluated by the health-care professionals and patients based on the individual treatment goals. Each goal is either rated as “successful”, “partially successful”, or “not successful”.

2.4. Observer-Reported and Performance Outcomes

The Karnofsky Performance Scale Index is a tool for observer-based assessments of the functional impairment of patients. Impairment of the patients’ activity, autonomy, and self-care abilities was rated on a 0–100% spectrum, with higher scores indicating better levels of functioning. In our study, the score was summarized as follows: high level of functioning (80–100%), medium level of functioning (50–80%), and low level of functioning (0–50%). To evaluate the physical fitness, a six-minute walk test (6-MWT) was applied at the beginning and end of the rehabilitation stay for children who were old enough and physically developed enough to perform the test. Body mass index (BMI) was extracted from the clinic’s information system.

2.5. Statistical Analysis

Differences in mean PedsQL scores between child self-assessment and parent proxy ratings were tested for statistical significance using independent sample t-tests. Multivariate analyses of variance (MANOVA) applying Pillai’s Trace were applied to compare baseline scores of patients with complete datasets, as well as to investigate differences in PedsQL baseline scores across cancer types. Changes in HRQOL (PedsQL), walking distance (6-MWT), and functional status (Karnofsky Index) between the two time points were analyzed using repeated measures ANOVAs. For the PedsQL, analyses were conducted separately for the patient self-reports and parent proxy reports. The frequency of individual treatments is presented with median and interquartile ranges (IQR). Partial eta-squared (η2), Cohens’ d, and Phi (ϕ) were calculated as measures of effect sizes. Effect size values of d = 0.3, η2 = 0.01, and ϕ = 0.1 were considered small; d = 0.5, η2 = 0.06, and ϕ = 0.3 were medium; and d = 0.8, η2 = 0.14, and ϕ = 0.5 were large [36].
Concordance and differences between patient-reported outcomes (i.e., children’s self-assessment) and the parent’s proxy ratings were evaluated by calculation of interclass correlation coefficients (rICC; two-way mixed, absolute agreement) for all PedsQL subscales separately. To test the overall agreement between the children’s and parent’s ratings, we applied z-transformation to all PedsQL subscales at T1 and T2 separately for the child and parent ratings and calculated a mean score across both measurement points for children and parents. The correlation of these z-transformed mean scores for children and parents was then also analyzed with rICC. Values of rICC less than 0.5, between 0.5 and 0.75, between 0.75 and 0.9, and greater than 0.90 were interpreted as poor, moderate, good, and excellent reliability, respectively [37]. It has been previously reported that due to baseline differences the calculation of change scores may lead to ceiling effects and thus may distort the interpretation of therapy effectiveness across groups with differences in baseline values. If, for example, a patient already reports good HRQOL scores before rehabilitation, no substantial increase (change) is expected during rehabilitation. In this case, although the patient’s overall performance may be good, only a slight or no increase can be measured by simply calculating the mean difference. A simple solution might be the use of the “performance score (T2D)”, based on the formula T2 + (T2T1), which reflects the individual performance and considers the functional status at the beginning of rehabilitation (changes from T1 to T2; Δ) without problems of mathematical coupling or regression effects, as seen in ANCOVA [31,38]. To test this approach, associations between the assessment of children and their parents for the mean differences between T1 and T2 (delta, Δ) as well as the performance score (T2D) were compared with Pearson correlation coefficients. Values of r < 0.3 were interpreted as negligible, while r = 0.3–0.5 indicated low, 0.5–0.7 moderate, 0.7–0.9 high, and >0.9 an excellent correlation [39,40,41]. To compare mean r-values of delta and T2D, r-scores were transformed to normally distributed variables z’ by Fisher z-transformation, and mean z-scores were transformed back to mean r-values. p values of <0.05 were considered statistically significant. All calculations were conducted with SPSS (v21).

3. Results

In total, n = 236 cancer survivors were included in the analyses. The mean age of the patients was 11 (SD: 4.3) years and 58.9% were male. The most frequent diagnoses were leukemias (35.2%), lymphomas (19.5%), and brain tumors (13.6%), and almost all patients (98.4%) had a medium to high functional status (Karnofsky Performance Score). The proxy sample consisted of n = 478 caregivers with a mean age of 42.1 (SD: 7.3) years; the majority of the sample was female (n = 306, 66.4%). The mean interval between admission to and discharge from the rehabilitation center was 28.0 (SD = 3.6) days. More details can be found in Table 2.
Compete datasets were available for n = 236 children at T1 and n = 182 children at T2 (77.1%). For parents, complete datasets were available for n = 478 participants at both assessment points. A total of n = 149 datasets with children’s PROs and parents proxy ratings (63.4%) could be matched.

3.1. HRQOL Reports Prior to Rehabilitation

We analyzed data from T1 to evaluate the patients’ health status prior to the rehabilitation treatment. Based on the children’s self-reports, the worst scores were found for procedural anxiety and school functioning, while for treatment anxiety, the best overall scores were reported. Parents, on the other hand, reported the lowest scores for their children for procedural anxiety, communication, and emotional functioning. Overall, parents reported significantly worse HRQOL on all scales except school functioning (diff = 2.0 points; t = 13.89, p = 0.17), treatment anxiety (diff = 1.4 points; t = 0.70, p = 0.48), and perceived physical appearance (diff = 2.6 points; t = 13.57, p = 0.18). The largest differences between the children’s self-assessment and parent proxy ratings were found for communication (diff = 20.6 points; t = 96.1, p < 0.001; d = 0.77), procedural anxiety (diff = 12.3 points; t = 43.68, p < 0.001, d = 0.34), and emotional functioning (diff = 11.6; t = 74.3, p < 0.001, d = 0.6), with medium to large effect sizes.
We also analyzed differences in the PedsQL subscales across the different cancer entities at baseline. Based on the children’s self-assessment, no significant differences were observed for any subscales (F (6, 225) = 1.09, p = 0.28). However, parents reported significant differences across the baseline PedsQL scores for different cancer entities regarding pain (F (6, 245) = 3.53, p = 0.002). Post-hoc tests showed that parents reported significantly worse pain scores for children with sarcoma (67.3 points; p = 0.004–0.043), leukemia (70.0 points; p < 0.001–0.011), brain tumors (72.7 points; p = 0.005), and malignant lymphomas (72.9 points; p = 0.010) compared to children with neoplasms of blood and immune system (83.9 points) and children with other malignancies (89.9 points). Accordingly, children with sarcomas (mean: 82.5%) had significantly lower overall Karnofsky Performance Scores compared to patients with malignant lymphomas (mean: 90.0%; p = 0.012) and leukemias (p = 0.003; 90.2%). No statistically significant differences were observed between the other cancer entities.

3.2. Improvement in HRQOL during Rehabilitation Treatment

3.2.1. Child Self-Report

Based on the children’s self-report, statistically significant improvements were observed for all functioning scales and most symptom scales at the end of the rehabilitation, except for treatment anxiety, worries, and perceived physical appearance. The largest effect sizes for improvements were found for physical functioning (diff = 7.5 points), psychosocial functioning (diff = 5.0 points), and school functioning (diff = 5.5 points). For details, see Table 3.

3.2.2. Proxy Ratings

Based on the proxy ratings, statistically significant improvements were observed for all variables, except communication. Generally, proxy ratings showed larger improvements than the children’s self-ratings. The largest effect sizes for improvements were found for emotional functioning (diff = 9.6 points), psychosocial functioning (diff = 7.5 points), and physical functioning (diff = 7.3 points). For details, see Table 4.

3.3. Improvement in Health Status and Goal Achievement during the Rehabilitation

A mean number of 3.7 goals (SD: 1.0) per patient were agreed on at the beginning of the rehabilitation treatment, and the number of individual goals ranged from 1 to 8 goals. The vast majority of patients (n = 185; 78.4%) had met all their individual goals during rehabilitation, and no patient reported that they did not meet any goals at all. Patients also showed a significant improvement in the mean walking distance at the end of rehabilitation compared to admission, with a large effect size (515.6 vs. 566.4 m; F (1, 160) = 70.30, p < 0.001, η2 = 0.31), as well as an improved observer-rated functional status (Karnofsky: 88.4% vs. 92.9%; F (1, 216) = 82.60, p < 0.001, η2 = 0.28), also with a large effect size. No statistically significant change was observed for the mean BMI (19.9 vs. 19.8; F (1, 115) = 1.14, p = 0.29, η2 = 0.01).

3.4. Patient–Proxy Discrepancies

In our sample, n = 149 dyads of complete PRO and proxy assessments were available at baseline (T1). Of these, 95/149 included proxy ratings from both parents and 54/149 from only one parent. The mothers’ assessments were available in 142/149 dyads, while 102/149 father–child dyads were available. At the end of rehabilitation (T2), n = 103 dyads were available. Of these 59/103 included proxy ratings from both parents and 42/103 from only one parent. The mothers’ assessments were available in 96/103 dyads, while 66/103 father–child dyads were available.
Overall agreement between children and parent ratings using z-transformed mean scores across both measurement points was good (rICC = 0.81; 95% CI: 0.73–0.87). However, when analyzing each time point separately, agreement for T1 (rICC = 0.72; 95% CI: 0.60–0.81) was lower than for T2 (rICC = 0.86; 95% CI: 0.79–0.91).
At the beginning of the rehabilitation treatment, child–mother dyads showed moderate correlations (rICC = 0.53–0.69) for functioning scales, with the highest agreement for physical functioning. For child–father dyads, similar results were found (rICC = 0.57–0.65). Regarding the assessment of symptoms, poor to moderate correlations were found between child–mother dyads (rICC = 0.49–0.84). They were, however, consistently higher than the child–father dyads (rICC = 0.40–0.78). In both dyads, the highest agreement was found for rating of procedural anxiety, while the communication (with health-care professionals) scale revealed no significant association in either dyad. Agreement between both parents was generally good (rICC = 0.76–0.86), except concerning cognitive problems (rICC = 0.61) and communication (rICC = 0.65). For details, see Table 5.
At the end of rehabilitation, the general agreement for functioning scales increased substantially in both child–mother (rICC = 0.77–0.88) and child–father dyads (rICC = 0.76–0.85), yielding good overall agreement between both parents and the child, as well as between both parents.
As for the symptom ratings, overall agreement between both parents and their child was also substantially better than before rehabilitation, with good to excellent agreement, except for cognitive problems (rICC = 0.40–0.64) and communication (rICC = −0.36–0.01). When separately analyzing both parents’ agreement with their child, fathers showed higher agreement regarding pain, nausea, procedural anxiety, and treatment anxiety, while mothers showed higher agreement regarding worries and perceived physical appearances. For details, see Table 6.

3.5. Accordance of Mean HRQOL Change Ratings by Children and Parents

To further evaluate the agreement between children and parents regarding mean change in HRQOL during rehabilitation, we evaluated the percentage of children responding with clinically important improvements (i.e., individual score changes above MCID) on the PedsQL Generic total score, based on the children’s self-report and parental proxy ratings for each cancer type separately. In general, while children reported lower rates of clinical improvement than their parents (53.3% vs. 58.4%), this difference was not statistically significant (χ2 = 1.36, p = 0.24; ϕ = 0.05). Children with soft tissue neoplasms (64.3%) and bone cancers (56.5%) reported the highest rates of clinically relevant improvements, while the lowest rates were found for patients with brain cancer (48.0%). Based on the parent proxy ratings, the highest rates were found for patients with malignant lymphomas (75.0%) and bone cancer (73.3%). However, the percentage of clinically relevant improvement did not significantly differ between tumor groups, either for children’s self-report (χ2 = 2.02, p = 0.92; ϕ = 0.11) nor for parents’ proxy ratings (χ2 = 7.31, p = 0.29; ϕ = 0.16). For details see Figure 1.
Secondly, we tested two further approaches to evaluate mean changes during rehabilitation: calculation of delta (i.e., mean difference), and performance score (adjusted delta). When comparing mean delta values, low to moderate agreement between children and parents was observed (r = 0.20–0.59), with generally better agreement for functioning scales (r = 0.59) than for symptom scales (r = 0.45). While the highest agreements were observed for psychosocial functioning and physical functioning, no significant association was found for nausea, worries, communication, or the overall symptom rating. For details, see Table 7.
A comparison of the children’s and parents’ performance scores yielded substantially improved agreement for all assessed subscales, with at least moderate correlations (r = 0.29–0.68). For functioning scales, the largest improvements were found for emotional functioning, social functioning, and school functioning. However, improvements in accordance were substantially larger regarding the symptom subscales, with the largest improvement for procedural anxiety, treatment anxiety, and nausea. For all subscales, except for communication, a significant association between the children’s self-assessment and parental proxy ratings could be observed. In summary, the mean correlation between children and parents was significantly higher for the T2D performance score than for the delta (r = 0.50 vs. r = 0.34; z = −1.668; p = 0.048). For details, see Table 7.

4. Discussion

The aim of this study was to analyze changes in HRQOL and observable indicators of physical functioning in children after cancer treatment during the course of a four-week multidisciplinary inpatient rehabilitation treatment. To our knowledge, this is the largest study on inpatient rehabilitation for pediatric cancer survivors analyzing both self-reported and observer/proxy measures of health. We observed large and clinically meaningful improvements across the most assessed functional aspects of HRQOL and observable indicators of physical functioning. The use of the performance score led to a substantially better concordance between the children’s self-assessment and parental proxy ratings.
Since studies have shown that children with cancer and their parents commonly disagree on less observable aspects of HRQOL [16,23,42], we analyzed both the children’s self-report as well as their parents’ proxy reports to gain a full picture of the children’s health. At baseline, children reported most problems with anxiety related to medical procedures (i.e., procedural anxiety) and school-related factors, while parents additionally highlighted emotional problems and issues with communicating about their disease. Previous studies show that the vast majority of childhood cancer survivors (>85%) have to face at least one form of late effect, such as problems with cognition, body image, fatigue, chronic pain, or depression, that interfered with their ability to participate in major life activities [43]. These issues are associated with several long-term consequences. In a large-scale study that investigated the needs of >12,000 survivors of childhood cancer, school problems were frequently reported. Almost a fourth of the sample had to use special education services, and the likelihood of finishing school or college was significantly reduced for children with various cancer types when compared to their siblings [44]. Poor mental health among childhood cancer survivors was associated with lower income or unemployment and a reduced likelihood of marriage [45]. Problems with communication have been identified as a common problem among children with cancer, and merit specific interventions targeting language skills [46], since they may further increase the risk of unemployment [47]. This may explain the high uptake of speech therapy (>87%) in our sample. In regard to type of malignancy, we found no statistically significant differences for any of the children’s self-assessed PedsQL scales at baseline. However, when comparing parent rated PedsQL scales as well as the Karnofsky Performance score, patients with sarcomas showed significantly worse pain and performance scores than patients with other malignancies. This is in line with previous research, which has found parent-reported cancer specific HRQoL impairment after treatment in children with cancer [48].
Children and their parents showed substantial discrepancies in their assessment of the child’s functional status, especially regarding communication, procedural anxiety, and emotional functioning. Parents generally reported lower HRQOL scores at baseline than the children themselves. Comparisons of clinician-rated performance status, parental proxy ratings, and children’s self-reports indicate that differences between reporters are most likely a matter of perspective, rather than insufficient internal consistencies of the measures [49]. In contrast to a recent study on children during active chemotherapy [27], we found rather good agreement between mothers’ and fathers’ proxy ratings of their child and the children’s self-assessment. However, the observed agreement was substantially better at the end of rehabilitation treatment than before the treatment. One possible explanation is that the parents proxy ratings are connected to the children’s health status, i.e., that parents’ observations of their child’s HRQOL are more accurate if the child is healthier. This would also explain why accordance between parents is better in cancer survivors than in children during active chemotherapy [27,50]. This aspect may be analyzed in more detail in future studies. Discrepancies between parental ratings and the children’s self-reports may be influenced by several factors, including the parents’ own psychological distress [51,52]. It thus may be considered a strength of family-oriented inpatient rehabilitation that (psychological) treatment can be offered not only to the child, but to the whole family system [53].
Discordance between children’s PROs and parental proxy ratings are problematic in pediatric oncology since both approaches are frequently used in combination. However, so far, no guidelines offer recommendations to clinicians or researchers concerning how to handle discrepant results. In our study, for example, children reported no significant mean improvement in treatment anxiety, while parents observed a statistically highly significant difference with a moderate effect size. If this subdomain had been a priori defined as a primary or secondary outcome, it would not be clear how to interpret the results. Therefore, we also tested the so-called “performance score”, which was recently introduced as a more robust method to compare health assessments, taking into account different individual baseline results [38]. By correcting the delta for the T2 scores, the performance score is supposed to improve interpretability of change scores across different assessment types or groups with differing baseline scores. However, it has to be highlighted that while the T2D may help to identify real differences (positive and negative or neutral) and to reduce bias associated with delta scores, this does not automatically result in more ‘positive’ results. In our study, we found a substantially increased accordance between children’s self-assessment and parental proxy ratings when applying the performance scores. Additionally, while based on the mean change (delta) solely, we found no significant correlation between the child’s self-assessment of change and parental proxy ratings for nausea, worries, and communication based on the use of the performance score. Only the communication subscale showed no significant association. Based on these preliminary findings, we recommend further research on the use of the performance score in pediatric oncology and rehabilitation research.
In our sample, the largest improvements during treatment were observed for physical functioning and psychosocial functioning from both children and parents. The effect sizes were comparable to research from adult rehabilitation populations [54]. Generally, parents reported larger improvements in all assessed HRQOL scales than the children themselves. Since children with cancer are at an increased risk for impairments of strength, posture, dexterity, and flexibility due to the different treatment regimens [12], physical therapy is a core element of pediatric oncological rehabilitation. In our sample, physiotherapy was the most frequently applied intervention, with a median number of 36 treatments per patient. Physiotherapeutic treatment consisted of a wide range of individual and group activities, including exercises for strength, dexterity, and mobility, but also hydro gymnastics, wall climbing, and multiple outdoor activities. Additionally, almost all patients took part in occupational therapy, which aimed to improve fine motor skills, sensory motor skills, and visual motor skills. The improvement in the patients’ physical functioning was also underscored by the significant improvement in mean walking distance and general functional status reflected in the Karnofsky score.
Furthermore, core elements of the rehabilitation treatment were the psychological therapies, which included individual and group sessions, family-oriented interventions, cognitive training, as well as guided relaxation training. Patients received a median of 10.5 sessions during their inpatient treatment. While previous studies have highlighted the effectiveness of psychosocial interventions to improve children’s anxiety, depressive symptoms, and overall quality of life, as well as physical symptoms during active cancer treatment [55], research on psychosocial interventions in pediatric rehabilitation remains scarce. Thus, our study adds to the existing literature, highlighting the beneficial effects of integrated multidisciplinary inpatient treatment programs to improve the psychosocial health of pediatric cancer survivors.
To evaluate the impact of observed improvements across cancer types, we analyzed how many patients showed clinically important improvements (i.e., above the MCID). The MCID describes the smallest difference in a score that has been perceived as a meaningful improvement by a group of patients [56]. Since MCIDs are only established for the total score of the PedsQL Generic Module, our analysis of MCIDs was limited to this score. While the percentage of patients with clinically meaningful improvements differed across cancer types, these differences were not statistically significant. However, patients with neoplasms of the soft tissue showed the highest percentage of clinically important differences based on both parents’ and children’s ratings.
The present study has some limitations. For one, parental emotional distress was not assessed in the routine assessment at the rehabilitation center. Since parental distress is discussed as a potential confounder for the discrepancy between parental proxy ratings and children’s self-assessment, the inclusion of standardized measures for anxiety or depression for parents could have helped to explain variance. Secondly, the study is limited by its observational nature and the fact that no control group was available. Since pediatric cancer patients in Austria have the right to receive rehabilitation treatment, which is currently only available as an in-patient treatment, randomization to a control treatment was not possible legally. Nevertheless, we consider the sample to be representative of the target population, since we included a relatively large number of unselected patients. Thirdly, there is no instrument available that has been designed for pediatric cancer survivors specifically. Thus, the included scales may not be perfectly suited to evaluate rehabilitation programs for children who completed cancer therapy. However, the PedsQL is the most frequently used questionnaire in the field [57,58,59], which allows a certain comparability to other studies.

5. Conclusions

The results of our analysis show large and clinically relevant improvements in functioning and symptoms among survivors of childhood cancer undergoing multidisciplinary inpatient rehabilitation. This indicates that family-oriented oncological rehabilitation can effectively improve the bio-psycho-social health of pediatric cancer survivors, and may help to reduce long-term effects of cancer and its treatment and thus facilitate re-integration into daily life. The performance score led to substantially better agreement with regard to change assessment between children and parents, and should thus be integrated in future studies. Future research should also focus on the long-term effects of inpatient rehabilitation treatment for cancer survivors.

Author Contributions

Conceptualization, D.R., T.L. and G.F.; methodology, D.R. and V.G.; software, B.H. and G.R.; formal analysis, D.R.; data curation, A.N., T.L. and G.F.; writing—original draft preparation, D.R.; writing—review and editing, M.R., V.G., T.L., G.F., B.H., G.R. and M.J.F.; supervision, T.L. and G.F. All authors have read and agreed to the published version of the manuscript.

Funding

No funding was available. The costs of this investigator-initiated study were covered by the rehabilitation center at Sankt Veit im Pongau.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Commission of the State of Salzburg, Austria (administrative notice no. 415-EP/73/451-2014).

Informed Consent Statement

The patients and legal guardians signed an informed written consent prior to data collection.

Data Availability Statement

Data are part of the patients’ medical records at VAMED Rehabilitation Center Leuwaldhof (Austria). They were anonymized for statistical analysis. The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. Computer-based health evaluation software (CHES) was used for collection of electronic patient-reported outcome data. This software application is described under: https://ches.pro/. (accessed on 10 March 2022).

Acknowledgments

We thank Wolfgang Sperl for his scientific guidance and support in establishing paediatric rehabilitation and evaluating its results.

Conflicts of Interest

Gustav Fischmeister and Thomas Licht are employed as medical directors of the Leuwaldhof and Onkologisches Rehabilitationszentrum Sankt Veit im Pongau, where Alain Nickels is employed as the head of psycho-oncology. Maria Rothmund, Gerhard Rumpold, Bernhard Holzner, Vincent Grote, Michael Fischer, and David Riedl declare no conflicts of interest.

References

  1. Steliarova-Foucher, E.; Colombet, M.; Ries, L.A.G.; Moreno, F.; Dolya, A.; Bray, F.; Hesseling, P.; Shin, H.Y.; Stiller, C.A. IICC-3 contributors. International incidence of childhood cancer, 2001–2010: A population-based registry study. Lancet Oncol. 2017, 18, 719–731. [Google Scholar] [CrossRef]
  2. Gatta, G.; Botta, L.; Rossi, S.; Aareleid, T.; Bielska-Lasota, M.; Clavel, J.; Dimitrova, N.; Jakab, Z.; Kaatsch, P.; Lacour, B.; et al. Childhood cancer survival in Europe 1999–2007: Results of EUROCARE-5—a population-based study. Lancet Oncol. 2014, 15, 35–47. [Google Scholar] [CrossRef]
  3. Cancer Research UK. Children’s Cancer Statistics. 2018. Available online: http://www.cancerresearchuk.org/health-professional/cancer-statistics/childrens-cancers (accessed on 3 October 2022).
  4. Kaatsch, P.; Grabow, D.; Spix, C. German Childhood Cancer Registry—Annual Report 2016 (1980–2015); Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Center of the Johannes Gutenberg University Mainz: Mainz, Germany, 2016. [Google Scholar]
  5. Smith, M.A.; Altekruse, S.F.; Adamson, P.C.; Reaman, G.H.; Seibel, N.L. Declining childhood and adolescent cancer mortality. Cancer 2014, 120, 2497–2506. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Siegel, D.A.; King, J.; Tai, E.; Buchanan, N.; Ajani, U.A.; Li, J. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics 2014, 134, e945–e955. [Google Scholar] [CrossRef] [Green Version]
  7. National Cancer Institute. Children with Cancer—A Guide for Parents; National Institutes of Health: Bethesda, Maryland, 2015.
  8. Hudson, M.M.; Ness, K.K.; Gurney, J.G.; Mulrooney, D.A.; Chemaitilly, W.; Krull, K.R.; Green, D.M.; Armstrong, G.T.; Nottage, K.A.; Jones, K.E. Clinical ascertainment of health outcomes among adults treated for childhood cancer. Jama 2013, 309, 2371–2381. [Google Scholar] [CrossRef] [Green Version]
  9. Oeffinger, K.C.; Mertens, A.C.; Sklar, C.A.; Kawashima, T.; Hudson, M.M.; Meadows, A.T.; Friedman, D.L.; Marina, N.; Hobbie, W.; Kadan-Lottick, N.S.; et al. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 2006, 355, 1572–1582. [Google Scholar] [CrossRef]
  10. World Health Organization, W. Health Topics: Rehabilitation; WHO: Geneva, Switzerland, 2015. [Google Scholar]
  11. UNICEF. Convention on the Rights of the Child. 1990. Available online: https://www.ohchr.org/en/instruments-mechanisms/instruments/convention-rights-child (accessed on 10 March 2022).
  12. Gudbergsson, S.B.; Dahl, A.A.; Loge, J.H.; Thorsen, L.; Oldervoll, L.M.; Grov, E.K. What is covered by “cancer rehabilitation” in PubMed? A review of randomized controlled trials 1990–2011. J. Rehabil. Med. 2015, 47, 97–106. [Google Scholar] [CrossRef] [Green Version]
  13. Tanner, L.; Keppner, K.; Lesmeister, D.; Lyons, K.; Rock, K.; Sparrow, J. Cancer Rehabilitation in the Pediatric and Adolescent/Young Adult Population. Semin. Oncol. Nurs. 2020, 36, 150984. [Google Scholar] [CrossRef]
  14. Maehr, B.; Keilani, M.; Wiltschke, C.; Hassler, M.; Licht, T.; Marosi, C.; Huetterer, E.; Cenik, F.; Crevenna, R. Cancer rehabilitation in Austria-aspects of Physical Medicine and Rehabilitation. Wien. Med. Wochenschr. 2016, 166, 39–43. [Google Scholar] [CrossRef]
  15. European Medicines Agency (EMA). Appendix 2 to The Guideline on The Evaluation of Anticancer Medicinal Products in Man: The Use of Patient-Reported Outcome (PRO) Measures in Oncology Studies. 2016. Available online: https://www.ema.europa.eu/en/documents/other/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf (accessed on 10 March 2022).
  16. U.S. Food and Drug Administration (FDA). Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009; U.S. Food and Drug Administration: Rockville, MD, USA.
  17. Eiser, C.; Varni, J.W. Health-related quality of life and symptom reporting: Similarities and differences between children and their parents. Eur. J. Pediatr. 2013, 172, 1299–1304. [Google Scholar] [CrossRef]
  18. Ravens-Sieberer, U.; Karow, A.; Barthel, D.; Klasen, F. How to assess quality of life in child and adolescent psychiatry. Dialogues Clin. Neurosci. 2014, 16, 147–158. [Google Scholar] [CrossRef]
  19. Varni, J.W.; Limbers, C.A.; Burwinkle, T.M. Parent proxy-report of their children’s health-related quality of life: An analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales. Health Qual. Life Outcomes 2007, 5, 2. [Google Scholar] [CrossRef] [Green Version]
  20. Ronen, G.M.; Streiner, D.L.; Rosenbaum, P. Health-related quality of life in children with epilepsy: Development and validation of self-report and parent proxy measures. Epilepsia 2003, 44, 598–612. [Google Scholar] [CrossRef]
  21. Mack, J.W.; McFatrich, M.; Withycombe, J.S.; Maurer, S.H.; Jacobs, S.S.; Lin, L.; Lucas, N.R.; Baker, J.N.; Mann, C.M.; Sung, L.; et al. Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment. JAMA Pediatr. 2020, 174, e202861. [Google Scholar] [CrossRef]
  22. Parsons, S.K.; Fairclough, D.L.; Wang, J.; Hinds, P.S. Comparing longitudinal assessments of quality of life by patient and parent in newly diagnosed children with cancer: The value of both raters’ perspectives. Qual. Life Res. 2012, 21, 915–923. [Google Scholar] [CrossRef]
  23. Weaver, M.S.; Jacobs, S.S.; Withycombe, J.S.; Wang, J.; Greenzang, K.A.; Baker, J.N.; Hinds, P.S. Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy. JAMA Netw. Open 2022, 5, e221855. [Google Scholar] [CrossRef]
  24. Upton, P.; Lawford, J.; Eiser, C. Parent-child agreement across child health-related quality of life instruments: A review of the literature. Qual. Life Res. 2008, 17, 895–913. [Google Scholar] [CrossRef]
  25. Davis, E.; Davies, B.; Waters, E.; Priest, N. The relationship between proxy reported health-related quality of life and parental distress: Gender differences. Child Care Health Dev. 2008, 34, 830–837. [Google Scholar] [CrossRef]
  26. Waters, E.; Doyle, J.; Wolfe, R.; Wright, M.; Wake, M.; Salmon, L. Influence of parental gender and self-reported health and illness on parent-reported child health. Pediatrics 2000, 106, 1422–1428. [Google Scholar] [CrossRef]
  27. Yeh, C.H.; Chang, C.W.; Chang, P.C. Evaluating quality of life in children with cancer using children’s self-reports and parent-proxy reports. Nurs. Res. 2005, 54, 354–362. [Google Scholar] [CrossRef]
  28. Meryk, A.; Kropshofer, G.; Hetzer, B.; Riedl, D.; Lehmann, J.; Rumpold, G.; Haid, A.; Schneeberger-Carta, V.; Salvador, C.; Rabensteiner, E.; et al. Disagreement between mothers’ and fathers’ rating of health-related quality of life in children with cancer. Qual. Life Res. 2022. submitted. [Google Scholar]
  29. Riedl, D.; Giesinger, J.M.; Wintner, L.M.; Loth, F.L.; Rumpold, G.; Greil, R.; Nickels, A.; Licht, T.; Holzner, B. Improvement of quality of life and psychological distress after inpatient cancer rehabilitation: Results of a longitudinal observational study. Wien. Klin. Wochenschr. 2017, 129, 692–701. [Google Scholar] [CrossRef]
  30. Licht, T.; Nickels, A.; Rumpold, G.; Holzner, B.; Riedl, D. Evaluation by electronic patient-reported outcomes of cancer survivors’ needs and the efficacy of inpatient cancer rehabilitation in different tumor entities. Support. Care Cancer 2021, 29, 5853–5864. [Google Scholar] [CrossRef]
  31. Klocker, J.; Klocker-Kaiser, U.; Pipam, W.; Geissler, D. Long-term improvement of the bio-psycho-social state of cancer patients after 3 weeks of inpatient oncological rehabilitation: A long-term study at the Humanomed Zentrum Althofen. Wien. Med. Wochenschr. 2018, 168, 350–360. [Google Scholar] [CrossRef]
  32. Lehmann, J.; Rothmund, M.; Riedl, D.; Rumpold, G.; Grote, V.; Fischer, M.J.; Holzner, B. Clinical Outcome Assessment in Cancer Rehabilitation and the Central Role of Patient-Reported Outcomes. Cancers 2021, 14, 84. [Google Scholar] [CrossRef]
  33. Holzner, B.; Giesinger, J.M.; Pinggera, J.; Zugal, S.; Schöpf, F.; Oberguggenberger, A.S.; Gamper, E.M.; Zabernigg, A.; Weber, B.; Rumpold, G. The Computer-based Health Evaluation Software (CHES): A software for electronic patient-reported outcome monitoring. BMC Med. Inform. Decis. Mak. 2012, 12, 126. [Google Scholar] [CrossRef] [Green Version]
  34. Varni, J.W.; Burwinkle, T.M.; Seid, M.; Skarr, D. The PedsQL 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul. Pediatr. 2003, 3, 329–341. [Google Scholar] [CrossRef]
  35. Varni, J.W.; Burwinkle, T.M.; Katz, E.R.; Meeske, K.; Dickinson, P. The PedsQL in pediatric cancer: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002, 94, 2090–2106. [Google Scholar] [CrossRef]
  36. WHO. International Classification of Functioning, Disability and Health (ICF). 2001. Available online: https://www.who.int/classifications/international-classification-of-functioning-disability-and-health (accessed on 10 August 2022).
  37. Ellis, P.D. The Essential Guide to Effect Sizes: Statistical Power, Meta-Analysis, and The Interpretation of Research Results; Cambridge University Press: Cambridge, UK; New York, NY, USA, 2010. [Google Scholar]
  38. Koo, T.K.; Li, M.Y. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J. Chiropr. Med. 2016, 15, 155–163. [Google Scholar] [CrossRef] [Green Version]
  39. Zdravkovic, A.; Grote, V.; Pirchl, M.; Stockinger, M.; Crevenna, R.; Fischer, M.J. Comparison of patient- and clinician-reported outcome measures in lower back rehabilitation: Introducing a new integrated performance measure (T2D). Qual. Life Res. 2022, 31, 303–315. [Google Scholar] [CrossRef]
  40. Hinkle, D.E.; Wiersma, W.; Jurs, S.G. Applied Statistics for the Behavioral Sciences; Houghton Mifflin: Boston, MA, USA, 2003; Volume 5. [Google Scholar]
  41. Bily, W.; Jauker, J.; Nics, H.; Grote, V.; Pirchl, M.; Fischer, M.J. Associations between Patient-Reported and Clinician-Reported Outcome Measures in Patients after Traumatic Injuries of the Lower Limb. Int. J. Environ. Res. Public Health 2022, 19, 3140. [Google Scholar] [CrossRef] [PubMed]
  42. Grote, V.; Pirchl, M.; Fischer, M.J. A new perspective on stratified outcome evaluation. J. Int. Soc. Phys. Rehabil. Med. 2021, 4, 118. [Google Scholar]
  43. Eiser, C.; Morse, R. Can parents rate their child’s health-related quality of life? Results of a systematic review. Qual. Life Res. 2001, 10, 347–357. [Google Scholar] [CrossRef] [PubMed]
  44. Berg, C.; Hayashi, R.J. Participation and Self-Management Strategies of Young Adult Childhood Cancer Survivors. OTJR Occup. Particip. Health 2012, 33, 21–30. [Google Scholar] [CrossRef]
  45. Mitby, P.A.; Robison, L.L.; Whitton, J.A.; Zevon, M.A.; Gibbs, I.C.; Tersak, J.M.; Meadows, A.T.; Stovall, M.; Zeltzer, L.K.; Mertens, A.C. Childhood Cancer Survivor Study Steering Committee. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 2003, 97, 1115–1126. [Google Scholar] [CrossRef]
  46. Ness, K.K.; Gurney, J.G.; Zeltzer, L.K.; Leisenring, W.; Mulrooney, D.A.; Nathan, P.C.; Robison, L.L.; Mertens, A.C. The impact of limitations in physical, executive, and emotional function on health-related quality of life among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Arch. Phys. Med. Rehabil. 2008, 89, 128–136. [Google Scholar] [CrossRef]
  47. Taylor, O.D.; Ware, R.S.; Weir, K.A. Speech pathology services to children with cancer and nonmalignant hematological disorders. J. Pediatr. Oncol. Nurs. 2012, 29, 98–108. [Google Scholar] [CrossRef]
  48. Pang, J.W.; Friedman, D.L.; Whitton, J.A.; Stovall, M.; Mertens, A.C.; Robison, L.L.; Weiss, N.S. Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr. Blood Cancer 2008, 50, 104–110. [Google Scholar] [CrossRef]
  49. Maurer, S.H.; Hinds, P.S.; Reeve, B.B.; Mack, J.W.; McFatrich, M.; Lin, L.; Withycombe, J.S.; Jacobs, S.S.; Baker, J.N.; Castellino, S.M. Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials. Cancer 2021, 127, 3664–3670. [Google Scholar] [CrossRef]
  50. Rensen, N.; Steur, L.M.H.; Schepers, S.A.; Merks, J.H.M.; Moll, A.C.; Kaspers, G.J.L.; Van Litsenburg, R.R.L.; Grootenhuis, M.A. Determinants of health-related quality of life proxy rating disagreement between caregivers of children with cancer. Qual. Life Res. 2020, 29, 901–912. [Google Scholar] [CrossRef] [Green Version]
  51. Davis, E.; Mackinnon, A.; Waters, E. Parent proxy-reported quality of life for children with cerebral palsy: Is it related to parental psychosocial distress? Child Care Health Dev. 2012, 38, 553–560. [Google Scholar] [CrossRef]
  52. Panepinto, J.A.; Hoffmann, R.G.; Pajewski, N.M. The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease. Pediatr. Blood Cancer 2010, 55, 714–721. [Google Scholar] [CrossRef]
  53. Krauth, K.A. Family-Oriented Rehabilitation (FOR) and Rehabilitation of Adolescents and Young Adults (AYA) in Pediatric Oncology. Oncol. Res. Treat. 2017, 40, 752–758. [Google Scholar] [CrossRef]
  54. Grote, V.; Unger, A.; Böttcher, E.; Muntean, M.; Puff, H.; Marktl, W.; Mur, E.; Kullich, W.; Holasek, S.; Hofmann, P. General and Disease-Specific Health Indicator Changes Associated with Inpatient Rehabilitation. J. Am. Med. Dir. Assoc. 2020, 21, 2017.e10–2017.e27. [Google Scholar] [CrossRef]
  55. Coughtrey, A.; Millington, A.; Bennett, S.; Christie, D.; Hough, R.; Su, M.T.; Constantinou, M.P.; Shafran, R. The Effectiveness of Psychosocial Interventions for Psychological Outcomes in Pediatric Oncology: A Systematic Review. J. Pain Symptom Manag. 2018, 55, 1004–1017. [Google Scholar] [CrossRef] [Green Version]
  56. Copay, A.G.; Subach, B.R.; Glassman, S.D.; Polly, D.W., Jr.; Schuler, T.C. Understanding the minimum clinically important difference: A review of concepts and methods. Spine J. 2007, 7, 541–546. [Google Scholar] [CrossRef]
  57. de Rojas, T.; Neven, A.; Towbin, A.J.; Carceller, F.; Bautista, F.; Riedl, D.; Sodergren, S.; Darlington, A.S.; Fernandez-Teijeiro, A.; Moreno, L. Clinical research tools in pediatric oncology: Challenges and opportunities. Cancer Metastasis Rev. 2020. ahead of print. [Google Scholar] [CrossRef]
  58. Riedl, D.; Rothmund, M.; Darlington, A.S.; Sodergren, S.; Crazzolara, R.; de Rojas, T.; EORTC Quality of Life Group. Rare use of patient-reported outcomes in childhood cancer clinical trials - a systematic review of clinical trial registries. Eur. J. Cancer 2021, 152, 90–99. [Google Scholar] [CrossRef]
  59. Rothmund, M.; Lehmann, J.; Moser, W.; de Rojas, T.; Sodergren, S.C.; Darlington, A.S.; Riedl, D. Patient-reported outcomes are under-utilised in evaluating supportive therapies in paediatric oncology—a systematic review of clinical trial registries. Crit. Rev. Oncol. Hematol. 2022, 176, 103755. [Google Scholar] [CrossRef]
Figure 1. Percentage of patients with clinically relevant improvement based on the PedsQL total score presented for each cancer entity for patient self-report and proxy reports.
Figure 1. Percentage of patients with clinically relevant improvement based on the PedsQL total score presented for each cancer entity for patient self-report and proxy reports.
Cancers 14 04855 g001
Table 1. Treatment modalities: overview over therapeutic measures per patient during the rehabilitation.
Table 1. Treatment modalities: overview over therapeutic measures per patient during the rehabilitation.
Treatment Modalityn(%)Treatment Frequency per Patient
MedianIQR
Guidance and treatment by physician236(100.0%)65–7
Nursing procedures236(100.0%)43–8
Speech therapy206(87.3%)21–4
Nutritional counseling236(100.0%)54–6
Social counseling226(95.8%)21.75–2
Physiotherapy236(100.0%)3630–42
Massage179(75.8%)32–4
Functional occupational therapy235(99.6%)1310–16
Animal assisted therapy55(23.3%)11–2
Psychological therapy236(100.0%)10.59–13
Pedagogical interventions161(68.2%)32–5
n: number of patients who received specific treatment at least once (percentage of patients of the whole collective); IQR: interquartile range.
Table 2. Patient characteristics pediatric oncological rehabilitation (n = 236).
Table 2. Patient characteristics pediatric oncological rehabilitation (n = 236).
Mean age (SD)11.0(4.3)
(range)(5–22)
Sex
Male13958.9%
Female9741.1%
Mean body mass index, BMI (SD)20.0(5.0)
(range)(12.7–33.1)
Mean initial walking range in meter (SD)519.6(118.6)
(range)(0–745)
Karnofsky Performance Score
High level of functioning (80–100%)18377.5%
Medium level of functioning (50–80%)4920.8%
Low level of functioning (0–50%)20.8%
Missing information20.8%
Cancer Entities
Leukemias (C91–C96)8335.2%
Malignant lymphoma (C81–C86; C88)4619.5%
Brain cancers (C70–72)3213.6%
Bone cancer (C40–C41)2711.4%
Neoplasms of soft tissue (C47–C49)187.6%
Neoplasms of blood and immune system (D50–D89)156.4%
Other156.4%
Table 3. Self-reported quality of life before and after rehabilitation (child report).
Table 3. Self-reported quality of life before and after rehabilitation (child report).
T1
(n = 236)
T2
(n = 182)
diff
Mean(SD)Mean(SD)(T2-T1)p-Valueη2
PedsQL generic core scale
Physical functioning73.919.681.415.67.5<0.0010.183
Emotional functioning76.220.781.518.65.3<0.0010.088
Social functioning79.916.584.217.44.30.0050.043
School functioning71.118.476.619.05.5<0.0010.116
Psychosocial functioning75.814.680.815.15.0<0.0010.123
Total score75.114.581.013.85.9<0.0010.180
PedsQL Cancer Module
Pain and hurt76.923.380.223.23.30.0330.025
Nausea79.118.181.816.72.70.0250.028
Procedural anxiety69.433.376.131.56.70.0350.025
Treatment anxiety86.320.587.520.91.20.270.007
Worry 77.724.979.621.61.90.0560.020
Cognitive problems76.420.879.021.32.60.0350.024
Perceived physical appearance79.622.480.222.00.60.88<0.01
Communication78.623.783.222.34.60.0100.037
Total score78.014.280.914.82.90.0040.045
SD—standard deviation, p-value—level of significance, diff—mean difference; η2—effect size (partial eta square); effect size is considered small for η2 > 0.01, medium for η2 > 0.06, and large for η2 > 0.14.
Table 4. Self-reported quality of life of the pediatric patients before and after rehabilitation (parent report).
Table 4. Self-reported quality of life of the pediatric patients before and after rehabilitation (parent report).
T1
(n = 478)
T2
(n = 478)
diff
Mean(SD)Mean(SD)(T2-T1)p-Valueη2
PedsQL generic core scale
Physical functioning70.720.578.019.47.3<0.0010.215
Emotional functioning64.718.674.317.99.6<0.0010.276
Social functioning73.318.778.618.95.3<0.0010.124
School functioning69.119.676.619.17.5<0.0010.141
Psychosocial functioning69.014.876.515.87.5<0.0010.274
Total score69.615.277.015.87.4<0.0010.305
PedsQL Cancer Module
Pain and hurt72.024.978.622.66.6<0.0010.093
Nausea74.319.579.018.44.7<0.0010.084
Procedural anxiety57.136.168.735.011.6<0.0010.169
Treatment anxiety79.423.584.522.15.1<0.0010.070
Worry 76.324.982.223.05.9<0.0010.090
Cognitive problems65.522.268.522.83.00.0090.020
Perceived physical appearance77.024.781.322.04.3<0.0010.048
Communication57.728.857.431.1−0.20.84<0.01
Total score69.714.774.815.55.1<0.0010.176
SD—standard deviation, p-value—level of significance, diff—mean difference; η2—effect size (partial eta square); effect size is considered small for η2 > 0.01, medium for η2 > 0.06, and large for η2 > 0.14.
Table 5. Associations of the children’s self-report and parental proxy ratings before rehabilitation (t0), stratified by patient–mother and patient–father dyads.
Table 5. Associations of the children’s self-report and parental proxy ratings before rehabilitation (t0), stratified by patient–mother and patient–father dyads.
PatientMotherFatherPatient–Mother DyadPatient–Father DyadMother–Father Dyad
mSDmSDmSDrICC95% CIprICC95% CIprICC95% CIp
Functioning scales
PF78.219.172.018.468.119.80.69 0.51–0.80<0.0010.650.37–0.79<0.0010.760.64–0.84<0.001
EF76.719.760.819.964.619.70.580.08–0.78<0.0010.570.25–74<0.0010.860.79–0.91<0.001
SF81.714.275.115.874.515.10.530.28–0.69<0.0010.590.34–0.74<0.0010.780.66–0.85<0.001
SchF74.916.569.319.269.816.90.650.47–0.77<0.0010.590.38–0.73<0.0010.80 0.70–0.87<0.001
PsF77.813.468.414.769.613.40.640.24–0.81<0.0010.630.29–0.79<0.0010.860.79–0.91<0.001
TotF77.913.169.614.369.113.90.660.31–0.81<0.0010.630.25–0.80<0.0010.840.77–0.90<0.001
Symptom scales
Pain80.421.869.324.071.625.70.730.48–0.85<0.0010.660.46–0.78<0.0010.810.71–0.87<0.001
Nausea80.117.570.020.169.820.30.610.31–0.77<0.0010.460.14–66<0.0010.82 0.71–0.88<0.001
Prod Anx67.733.259.535.063.233.00.840.74–0.90<0.0010.780.66–0.85<0.0010.820.74–0.88<0.001
Treat Anx87.219.678.123.180.521.30.610.38–0.75<0.0010.520.29–0.68<0.0010.770.66–0.85<0.001
Worry80.424.671.525.772.523.20.670.48–0.78<0.0010.640.45–0.76<0.0010.790.69–0.86<0.001
Cogn79.319.965.222.463.320.10.490.15–0.68<0.0010.400.03–0.63<0.0010.610.41–0.74<0.001
Perc Attr85.018.870.225.272.822.10.500.16–0.69<0.0010.570.26–0.74<0.0010.770.65–0.85<0.001
Comm77.824.553.728.752.829.4−0.36−0.97–0.080.98–0.17−0.59–0.160.860.650.48–0.77<0.001
TotSym79.513.469.614.369.113.90.520.15–0.71<0.0010.470.09–0.68<0.0010.840.77–0.90<0.001
m—mean score; SD—standard deviation; rICC—intraclass-correlation coefficient; CI—confidence interval; PF—physical functioning; EF—emotional functioning; SF—social functioning; SchF—school functioning; PsF—psychosocial functioning; TotF—total functioning score; Prod Anx—procedural anxiety; Treat Anx—treatment anxiety; Cogn—cognitive problems; Perc Attr—perceived physical appearances; comm—communication; TotSym—total symptom score; rICC < 0.5 = poor, 0.5–0.75 = moderate, 0.75–0.9 = good, and >0.9 = excellent reliability (Koo and Li, 2016) [38].
Table 6. Associations of the children’s self-report and parental proxy ratings after rehabilitation (T1), stratified by patient–mother and patient–father dyads.
Table 6. Associations of the children’s self-report and parental proxy ratings after rehabilitation (T1), stratified by patient–mother and patient–father dyads.
PatientMotherFatherPatient–Mother DyadPatient–Father DyadMother–Father Dyad
mSDmSDmSDrICC95% CIprICC95% CIprICC95% CIp
Functioning scales
PF83.514.580.416.378.318.40.860.76–0.91<0.0010.780.58–0.88<0.0010.860.78–0.91<0.001
EF79.920.074.520.373.920.50.770.62–0.86<0.0010.760.60–0.86<0.0010.880.81–0.93<0.001
SF85.316.482.916.980.517.60.840.73–0.90<0.0010.800.62–0.89<0.0010.820.71–0.89<0.001
SchF78.319.578.420.577.119.80.850.75–0.91<0.0010.810.68–0.88<0.0010.790.67–0.87<0.001
PsF81.015.178.617.177.317.10.870.78–0.92<0.0010.830.70–0.90<0.0010.860.77–0.91<0.001
TotF81.913.979.215.877.716.20.880.80–0.93<0.0010.850.69–0.92<0.0010.880.81–0.93<0.001
Symptom scales
Pain80.824.575.425.174.824.00.780.64–0.87<0.0010.870.77–0.92<0.0010.890.83–0.94<0.001
Nausea82.517.978.122.377.122.10.650.40–0.80<0.0010.740.55–0.86<0.0010.840.72–0.90<0.001
Prod Anx75.433.371.035.574.232.20.880.81–0.93<0.0010.910.85–0.95<0.0010.860.77–0.91<0.001
Treat Anx86.923.181.125.983.624.80.750.59–0.84<0.0010.820.71–0.89<0.0010.850.76–0.91<0.001
Worry81.021.879.023.974.126.00.810.68–0.88<0.0010.770.62–0.87<0.0010.790.68–0.87<0.001
Cogn80.720.568.423.965.122.30.640.32–0.80<0.0010.400.01–0.640.0040.500.21–0.69<0.001
Perc Attr84.020.280.223.875.825.40.740.58–0.84<0.0010.640.41–0.79<0.0010.820.72–0.89<0.001
Comm81.225.354.132.346.630.2−0.36−10.1–0.130.960.01−0.27–0.270.470.460.15–0.660.005
TotSym81.416.079.215.878.815.10.790.65–0.87<0.0010.820.69–0.89<0.0010.880.81–0.93<0.001
m—mean score; SD—standard deviation; rICC—intraclass-correlation coefficient; CI—confidence interval; PF—physical functioning; EF—emotional functioning; SF—social functioning; SchF—school functioning; PsF—psychosocial functioning; TotF—total functioning score; Prod Anx—procedural anxiety; Treat Anx—treatment anxiety; Cogn—cognitive problems; Perc Attr—perceived physical appearances; comm—communication; TotSym—total symptom score; rICC < 0.5 = poor, 0.5–0.75 = moderate, 0.75–0.9 = good, and >0.9 = excellent reliability (Koo and Li, 2016) [38].
Table 7. Comparison of agreement in mean improvement during therapy between children and parents using the delta and the performance score.
Table 7. Comparison of agreement in mean improvement during therapy between children and parents using the delta and the performance score.
Delta (n = 149)Performance Score (n = 149)
rp-Valuerp-Value
PedsQL generic core scale
Physical functioning0.51<0.0010.59<0.001
Emotional functioning0.36<0.0010.52<0.001
Social functioning0.37<0.0010.51<0.001
School functioning0.45<0.0010.60<0.001
Psychosocial functioning0.53<0.0010.65<0.001
Total score0.59<0.0010.68<0.001
PedsQL Cancer Module
Pain and hurt0.280.0040.42<0.001
Nausea0.190.100.40<0.001
Procedural anxiety0.200.0430.60<0.001
Treatment anxiety0.240.0160.50<0.001
Worry 0.090.370.330.001
Cognitive problems0.260.0090.290.003
Perceived physical appearance0.43<0.0010.49<0.001
Communication<0.010.99−0.090.35
Total score0.45<0.0010.60<0.001
Mean r-scores0.34 0.50
r—Pearson correlation coefficient; delta—mean difference during rehabilitation (T2-T1); performance score—adjusted delta (T2 + (T2-T1)); PF—physical functioning; EF—emotional functioning; SF—social functioning; SchF—school functioning; PsF—psychosocial functioning; TotF—total functioning score; Prod Anx—procedural anxiety; Treat Anx—treatment anxiety; Cogn—cognitive problems; Perc Attr—perceived physical appearances; Comm—communication; TotSym—total symptom score; r < 0.3 = negligible, r = 0.3–0.5 low, 0.5–0.7 moderate, 0.7–0.9 high, and >0.9 excellent correlation (Hinkle, Wiersma, and Jurs, 2003) [40].
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Riedl, D.; Licht, T.; Nickels, A.; Rothmund, M.; Rumpold, G.; Holzner, B.; Grote, V.; Fischer, M.J.; Fischmeister, G. Large Improvements in Health-Related Quality of Life and Physical Fitness during Multidisciplinary Inpatient Rehabilitation for Pediatric Cancer Survivors. Cancers 2022, 14, 4855. https://doi.org/10.3390/cancers14194855

AMA Style

Riedl D, Licht T, Nickels A, Rothmund M, Rumpold G, Holzner B, Grote V, Fischer MJ, Fischmeister G. Large Improvements in Health-Related Quality of Life and Physical Fitness during Multidisciplinary Inpatient Rehabilitation for Pediatric Cancer Survivors. Cancers. 2022; 14(19):4855. https://doi.org/10.3390/cancers14194855

Chicago/Turabian Style

Riedl, David, Thomas Licht, Alain Nickels, Maria Rothmund, Gerhard Rumpold, Bernhard Holzner, Vincent Grote, Michael J. Fischer, and Gustav Fischmeister. 2022. "Large Improvements in Health-Related Quality of Life and Physical Fitness during Multidisciplinary Inpatient Rehabilitation for Pediatric Cancer Survivors" Cancers 14, no. 19: 4855. https://doi.org/10.3390/cancers14194855

APA Style

Riedl, D., Licht, T., Nickels, A., Rothmund, M., Rumpold, G., Holzner, B., Grote, V., Fischer, M. J., & Fischmeister, G. (2022). Large Improvements in Health-Related Quality of Life and Physical Fitness during Multidisciplinary Inpatient Rehabilitation for Pediatric Cancer Survivors. Cancers, 14(19), 4855. https://doi.org/10.3390/cancers14194855

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop